I sold Aehr a few months back but was curious to see what happened. I’m fine staying on the sidelines - too small of a company, too much uncertainty, and the nail in the coffin for me was the slowdown in EV production by many of the major automakers. Stock down 19% AH.
Looks like a fairly decent quarter at quick glance, main issue was the FY24 forecast was reduced from “at least 100M” to be between $75 million and $85 million, and GAAP net income of between 20% and 25% of revenue. The reason for the downward revision was slowdown in EV’s.
"In the last sixty days, we have seen how the slowing of the growth rate of the electric vehicle market has had a negative impact on the timing of several current and new customer orders and capacity increases for silicon carbide devices used in them. For clarity, we do not see the silicon carbide market decreasing, only a temporary slowing of the growth rate. We are also experiencing the impact of shifts in our customers’ product mix, which specifically includes an increase in WaferPakTM full wafer contactors from our lead silicon carbide customer. The net of this is that we now expect a delay in the timing of new orders from current and new customers that will most likely impact this fiscal year’s revenue.
"Given the latest forecasts from our customers and the uncertainty on the timing of their orders, we believe it makes sense to take a more conservative approach to our fiscal year forecast and have reduced our growth estimates for fiscal 2024 revenue. We are reducing our revenue expectations of at least $100 million this fiscal year by 15% to 25% to a range of $75 million to $85 million dollars. This is still a growth rate of 15% to 30% year over year."
Fiscal Second Quarter Financial Results:
- Net revenue was $21.4 million, up 45% from $14.8 million in the second quarter of fiscal 2023.
- GAAP net income was $6.1 million, or $0.20 per diluted share, up 63% from GAAP net income of $3.7 million, or $0.13 per diluted share, in the second quarter of fiscal 2023.
- Non-GAAP net income, which excludes the impact of stock-based compensation, was $6.7 million, or $0.23 per diluted share, up 49% compared to non-GAAP net income of $4.5 million, or $0.16 per diluted share, in the second quarter of fiscal 2023.
- Bookings were $2.2 million for the quarter.
- Backlog as of November 30, 2023, was $3.0 million.
- Total cash and cash equivalents as of November 30, 2023 were $50.5 million, compared to $51.0 million at August 31, 2023.
Fiscal First Six Months Financial Results:
- Net revenue was $42.1 million, up 65% from $25.5 million in the first six months of fiscal 2023.
- GAAP net income was $10.8 million, or $0.36 per diluted share, up 149% compared to GAAP net income of $4.3 million, or $0.15 per diluted share, in the first six months of fiscal 2023.
- Non-GAAP net income was $11.9 million, or $0.40 per diluted share, which excludes the impact of stock-based compensation, up 105% compared to non-GAAP net income of $5.8 million, or $0.20 per diluted share, in the first six months of fiscal 2023.
- Cash provided by operations was $3.4 million for the first six months of fiscal 2024.
Full Press Release: